Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

100180

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many meetings the Parliamentary Under-Secretary of State for Public Health has had with James Palmer, Clinical Director for Specialised Commissioning at NHS England since 1 April 2014.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	211213
	answer	answer is ministerial correction date of answer 28/10/2014 answer text <p>I have had no meetings with James Palmer, Clinical Director for Specialised Commissioning at NHS England since 1 April 2014.</p><p> </p><p><strong> </strong></p><p> </p><p>There is regular contact between Departmental officials and Clinical Directors at NHS England, including the Clinical Director for Specialised Commissioning.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/10/2014 17:45:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

100181

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many meetings he has had with Simon Stevens, Chief Executive of NHS England since 1 April 2014.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	211214
	answer	answer is ministerial correction date of answer 28/10/2014 answer text <p>My Rt. hon. Friend, the Secretary of State, meets with Mr Stevens on a weekly basis with additional meetings arranged as and when required, which often include other members of the Ministerial team.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 28/10/2014 15:31:37 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	4089 label Biography information for Tessa Munt

100196

	registered interest
	date	21/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the signature authorising Individual Funding Requests made to NHS England for Gamma Knife treatment by University College Hospital London, Queen Square, is that of a senior clinician employed by University College Hospital London.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	211310
	answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We are advised by NHS England that the clinician who authorises Individual Funding Requests for Gamma Knife treatment to be undertaken at the Queens Square Radiology Centre Ltd (QSRC) is a surgeon at the National Hospital for Neurosurgery and Neurology (NHNN), part of University College London Hospitals NHS Foundation Trust (UCLH).</p><p> </p><p> </p><p> </p><p>Gamma Knife treatment is not undertaken by UCLH but by the private company QSRC, which is based at NHNN but has no formal relationship with UCLH.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:54:23 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

61874

	registered interest
	date	13/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Monitor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether guidance issued by Monitor is mandatory for NHS England to follow.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	200737
	answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>It is the National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013 that place requirements on NHS England, including requirements as to good practice in relation to procurement.</p><p> </p><p>Enforcement of the procurement requirements by Monitor may only follow its investigation of a complaint that there has been a failure by a commissioner to comply with the requirements. Guidance issued by Monitor on the regulations, including guidance issued in April, provides advice for commissioners on compliance with the regulations.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 23/06/2014 15:14:58 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

78009

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, for what reason none of the £42 million his Department has made available for increasing the use of radiotherapy is to be spent on treating cancer patients with Stereotactic Ablative Radiotherapy this year.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205834
	answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>In July 2011, the National Radiotherapy Implementation Group concluded that current evidence supports treatment withstereotactic ablative radiotherapy (SABR) for only a small number of patients. The evidence supports its use in the treatment of early stage lung cancers for patients who are unsuitable for surgery (approximately 1,000 per annum).</p><p> </p><p>NHS England recognises the positive clinical impact that its national policy on SABR for the treatment of early non-small cell lung cancer has had. It is currently examining the potential use of SABR in patients with oligometastatic disease – where a cancer is in the early stages of spreading.</p><p> </p><p>NHS England is also currently undertaking a review of stereotactic radiosurgery (SRS) and SABR for intracranial conditions to establish what the national demand is in line with its national clinical commissioning policies on SRS and SABR, and what the national capacity requirements are for this specialised treatment. Following the review it is planned that a final decision will be taken by the Specialised Commissioning Oversight Group in October 2014.</p><p> </p><p>Later this year, the Radiotherapy Clinical Reference Group will review its current policy position on SABR to assess whether there is new evidence to recommend its use on other conditions. It is important to ensure that treatments commissioned are supported by robust evidence of their benefit to patients.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 13:47:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

78013

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many individual funding requests per indication were received by NHS England for radiotherapy treatment in the last financial year; and how many requests, per indication, were refused by NHS England.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205953
	answer	answer is ministerial correction date of answer 21/07/2014 answer text <p>Since April 2013, radiotherapy treatment has been planned and paid for nationally by NHS England.</p><p> </p><p>NHS England has informed us that information on the number of individual funding requests made to NHS England is not currently available. NHS England is improving its data collection mechanisms and aims to improve availability of such information in the future.</p><p><br><br></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 21/07/2014 16:41:28 answering member 1439 label Biography information for Norman Lamb
	tabling member	4089 label Biography information for Tessa Munt

78017

	registered interest
	date	15/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Monitor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, to what extent NHS England is obliged to follow guidance issued by Monitor.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	205780
	answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>It is the National Health Service (Procurement, Patient Choice and Competition) (No. 2) Regulations 2013 that place requirements on NHS England, including requirements as to good practice in relation to procurement.</p><p> </p><p>Enforcement of the procurement requirements by Monitor may only follow its investigation of a complaint that there has been a failure by a commissioner to comply with the requirements. Monitor has published guidance for NHS England and other commissioners of healthcare services which provides advice on how to comply with the regulations. Monitor expects to follow the interpretation of the regulations that it has set out in its guidance when exercising its enforcement powers under the regulations.</p><p> </p><p>In addition, to the extent that NHS England acts as a commissioner of services, it has a legal duty to have regard to guidance which Monitor publishes for commissioners of services which are designated as ‘commissioner requested services’. Before publishing the guidance or any revisions to it, Monitor must have first consulted NHS England.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/07/2014 16:03:53 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

79378

	registered interest
	date	22/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, pursuant to the Answer of 21 July 2014, Official Report, column 1007W, on radiotherapy, when data relating to individual funding requests per indication for radiotherapy treatment made to NHS England and the number of such requests refused will be available from NHS England.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	206964
	answer	answer is ministerial correction date of answer 04/09/2014 answer text <p> </p><p>NHS England has advised us that it is aiming to complete its work on improving data collection for individual funding requests later this year. This will include information on requests received for radiotherapy treatments.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 04/09/2014 13:29:56 answering member 4020 label Biography information for George Freeman
	tabling member	4089 label Biography information for Tessa Munt

90319

	registered interest
	date	02/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people in what age group have been funded for proton beam therapy in each of the last five years; and in what location each person was so treated.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	207871
	answer	answer is ministerial correction date of answer 05/09/2014 answer text <p> </p><p>The information is provided in the following table:</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Children</p></td><td><p>Adults</p></td><td><p>Total</p></td><td><p>Location</p></td></tr><tr><td><p>2009-10</p></td><td><p>8</p></td><td><p>12</p></td><td><p>20</p></td><td><p>France, USA and Switzerland</p></td></tr><tr><td><p>2010-11</p></td><td><p>30</p></td><td><p>20</p></td><td><p>50</p></td><td><p>USA (38 patients) and Switzerland (12)</p></td></tr><tr><td><p>2011-12</p></td><td><p>66</p></td><td><p>13</p></td><td><p>79</p></td><td><p>USA (majority of patients) and Switzerland</p></td></tr><tr><td><p>2012-13</p></td><td><p>83</p></td><td><p>16</p></td><td><p>99</p></td><td><p>USA (majority of patients) and Switzerland</p></td></tr><tr><td><p>2013-14</p></td><td><p>103*</p></td><td><p>21*</p></td><td><p>124*</p></td><td><p>All USA</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>*Figure includes treatments given and treatments due to be given following approval.</p><p> </p><p> </p><p> </p><p>It is not possible to provide a more detailed analysis of age group by location of treatment because it might be possible to identify individual patients from the data.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/09/2014 13:12:09 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

90497

	registered interest
	date	03/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer Drugs Fund
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he authorised the recent increase in the Cancer Drug Fund annual budget; and whether (a) the Clinical Priorities Advisory Group and the Direct Commissioned Service Committee and (b) the Patient and Public Voice Assurance Group were consulted before that decision was taken.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	208020
	answer	answer is ministerial correction date of answer 10/09/2014 answer text <p> </p><p>My Rt hon Friend, the Secretary of State for Health, agreed that the size of the Cancer Drugs Fund would be increased to £280 million in both 2014-15 and 2015-16.</p><p> </p><p> </p><p> </p><p>We are advised by NHS England that the Clinical Priorities Advisory Group, the Direct Commissioned Service Committee and the Patient and Public Voice Assurance Group were not specifically consulted before this decision was taken.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 10/09/2014 12:33:03 answering member 4020 label Biography information for George Freeman
	tabling member	4089 label Biography information for Tessa Munt